Citation: P. Ruggenenti et al., ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop: A post hoc analysis of the REIN trial results, J AM S NEPH, 12(12), 2001, pp. 2832-2837
Citation: P. Ruggenenti et al., Thrombotic microangiopathies in the intensive care unit: Many questions, some answers, CONTR NEPHR, 132, 2001, pp. 53-67
Citation: P. Ruggenenti et al., Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura, KIDNEY INT, 60(3), 2001, pp. 831-846
Authors:
Jafar, TH
Stark, PC
Schmid, CH
Landa, M
Maschio, G
Marcantoni, C
de Jong, PE
de Zeeuw, D
Shahinfar, S
Ruggenenti, P
Remuzzi, G
Levey, AS
Citation: Th. Jafar et al., Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease, KIDNEY INT, 60(3), 2001, pp. 1131-1140
Authors:
Ruggenenti, P
Mosconi, L
Bruno, S
Remuzzi, A
Sangalli, F
Lepre, MS
Agazzi, R
Nani, R
Fasolini, G
Remuzzi, G
Citation: P. Ruggenenti et al., Post-transplant renal artery stenosis: The hemodynamic response to revascularization, KIDNEY INT, 60(1), 2001, pp. 309-318
Authors:
Ruggenenti, P
Pagano, E
Tammuzzo, L
Benini, R
Garattini, L
Remuzzi, G
Citation: P. Ruggenenti et al., Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies, KIDNEY INT, 59(1), 2001, pp. 286-294
Citation: P. Ruggenenti et al., Remission achieved in chronic nephropathy by a multidrug approach targetedat urinary protein excretion, NEPHRON, 88(3), 2001, pp. 254-259
Citation: P. Ruggenenti, Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: Differences between women and men in relation to the ace gene polymorphism (vol 11, pg 88, 2000), J AM S NEPH, 11(5), 2000, pp. NIL_67-NIL_67
Authors:
Ruggenenti, P
Perna, A
Zoccali, C
Gherardi, G
Benini, R
Testa, A
Remuzzi, G
Citation: P. Ruggenenti et al., Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: Differences between women and men in relation to the ACE gene polymorphism, J AM S NEPH, 11(1), 2000, pp. 88-96
Citation: P. Ruggenenti et G. Remuzzi, Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?, NEPH DIAL T, 15(12), 2000, pp. 1900-1902
Authors:
Ruggenenti, P
Perna, A
Gherardi, G
Benini, R
Remuzzi, G
Citation: P. Ruggenenti et al., Chronic proteinuric nephropathies: Outcomes and response to treatment in aprospective cohort of 352 patients with different patterns of renal injury, AM J KIDNEY, 35(6), 2000, pp. 1155-1165
Authors:
Ruggenenti, P
Mosconi, L
Vendramin, G
Moriggi, M
Remuzzi, A
Sangalli, F
Remuzzi, G
Citation: P. Ruggenenti et al., ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome, AM J KIDNEY, 35(3), 2000, pp. 381-391
Authors:
Neal, B
MacMahon, S
Chapman, N
Cutler, J
Fagard, R
Neal, B
Whelton, P
Yusuf, S
Agodoa, L
Baigent, C
Black, H
Boissel, JP
Brenner, B
Brown, M
Bulpitt, C
Byington, R
Chalmers, J
Collins, R
Dahlof, B
Davis, B
Estacio, R
Fox, K
Hansson, L
Holman, R
Hunsicker, L
Kostis, J
Kuramoto, K
Kusek, J
Lees, R
Lewis, E
Lindholm, LH
Liu, L
Lubsen, J
Malacco, E
Mancia, G
Martin, I
Pepine, C
Pfeffer, M
Pitt, B
Poole-Wilson, P
Remuzzi, G
Rodgers, A
Ruggenenti, P
Schrier, R
Sever, P
Sleight, P
Staessen, J
Teo, K
Turner, R
Wing, L
Zanchetti, A
Algert, C
Woodward, M
Citation: B. Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials, LANCET, 356(9246), 2000, pp. 1955-1964
Authors:
Ruggenenti, P
Perna, A
Lesti, M
Pisoni, R
Mosconi, L
Arnoldi, F
Ciocca, I
Gaspari, F
Remuzzi, G
Citation: P. Ruggenenti et al., Pretreatment blood pressure reliably predicts progression of chronic nephropathies, KIDNEY INT, 58(5), 2000, pp. 2093-2101
Authors:
Perna, A
Ruggenenti, P
Testa, A
Spoto, B
Benini, R
Misefari, V
Remuzzi, G
Zoccali, C
Citation: A. Perna et al., ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies, KIDNEY INT, 57(1), 2000, pp. 274-281
Authors:
Galbusera, M
Benigni, A
Paris, S
Ruggenenti, P
Zoja, C
Rossi, C
Remuzzi, G
Citation: M. Galbusera et al., Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, J AM S NEPH, 10(6), 1999, pp. 1234-1241
Authors:
Ruggenenti, P
Perna, A
Benini, R
Bertani, T
Zoccali, C
Maggiore, Q
Salvadori, M
Remuzzi, G
Citation: P. Ruggenenti et al., In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR, J AM S NEPH, 10(5), 1999, pp. 997-1006
Authors:
Noris, M
Ruggenenti, P
Perna, A
Orisio, S
Caprioli, J
Skerka, C
Vasile, B
Zipfel, PF
Remuzzi, G
Citation: M. Noris et al., Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Role of factor H abnormalities, J AM S NEPH, 10(2), 1999, pp. 281-293